Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Change in Management
Pursuant to Regulation 30 of SEBI Listing Regulations, we wish to inform you about the changes in senior management personnel of the Company.09-07-2024
Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Change in Management
Pursuant to Regulation 30 of SEBI Listing Regulations, we wish to inform you about the changes in senior management personnel of the Company.Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Change in Management
Pursuant to Regulation 30 of SEBI Listing Regulations, we wish to inform you about the change in senior management personnel of the Company.Alkem Laboratories Promoter Offloads Stake For Rs 177 Crore
Seema Singh offloaded 3.58 lakh shares at Rs 4,956 apiece, according to the block deal data on the NSE.Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
In furtherance of the intimation captioned "US FDA Inspection at Company''s manufacturing facility located at Baddi, India" dated 27th March, 2024, this is to inform you that the US FDA has issued an Establishment Inspection Report (EIR) for the said manufacturing facility of the Company located at Baddi, India.Alkem Laboratories Ltd - 539523 - Closure of Trading Window
This is to inform you that the trading window will remain closed from 29th June, 2024 until the expiry of 48hours after the date on which the Financial Results of the Company for quarter ended 30th June, 2024 are communicated to the Stock Exchanges.How Alkem's 83-year-old founder is remaking India's 4th-largest pharma firm
Hailing from Okari, a remote village in Jehanabad district of Bihar, Singh and his brother, Samprada, moved to Mumbai in 1973 to start Alkem Laboratories with a seed capital of Rs 5 lakhAlkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Resignation of Director
Dr. Dheeraj Sharma has tendered his resignation as an Independent Director of the Company vide email dated 14th June, 2024, due to pre-occupation. The requisite details as per SEBI (LODR) Regulations, 2015 are enclosed herewith.Alkem Laboratories Ltd - 539523 - Request For Reclassification Received From Certain Members Of Promoter Group Of The Company
This is in furtherance to our earlier intimation dated 9th February, 2024 in relation to proposed reclassification of certain members of Promoter Group of the Company to ''Public'' category.Alkem Laboratories Ltd - 539523 - Intimation Under Regulation 30 Of SEBI LODR - Regulatory Order
Pursuant to Regulation 30 of SEBI LODR, this is to inform you that the Company has received an order passed by statutory authority under Goods and Services Tax Act, 2017. The relevant disclosure is enclosed herewith.Alkem Laboratories Ltd - 539523 - Announcement under Regulation 30 (LODR)-Acquisition
We wish to inform you that the Company has agreed to invest in (Pre-Series A) Compulsorily Convertible Preference Shares of M/s HaystackAnalytics Private Limited. The requisite details with respect to the same are enclosed herewith.